Control of Fc and C3 receptors on myeloid leukemic cells. 1976

J Lotem, and L Sachs

An experimental system has been developed to study in cloned lines of cells the control of Fc and C3 receptors by different compounds. The cells used were clones of mouse myeloid leukemic cells and the compounds used were the protein MGI2 (macrophage and granulocyte inducer) in serum from mice injected with bacterial endotoxin and the steroid inducer (SI) dexamethasone. Eight clones were isolated which could be divided into three groups. One group (MGI+SI+) was induced to form EA and EAC rosettes by MGI and only EAC rosettes by SI, the second group (MGI-SI+) was not inducible by MGI but was induced by SI to form EA or EA and EAC rosettes, and the third group (MGI-SI-) was not inducible for EA or EAC by MGI or SI. There were two types of MGI+SI+ clones, one type (D+) could be induced by MGI to differentiate to mature macrophages and granulocytes, and the other type (D-) could not be induced to differentiate to mature cells. The MGI-SI+ and MGI-SI- clones were all D-. The results indicate that there are different cellular sites for MGI and SI and that induction of EA and EAC rosettes did not seem to be mediated by cyclic AMP. Experiments with specifically bound 3H-BSA-anti-BSA complexes have indicated that there was an increase in the amount of 3H-BSA-anti-BSA bound per rosette-forming cell following induction by MGI or SI, and there were differences in the amount of 3H-BSA-anti-BSA bound per rosette-forming cell in different clones. These clones also showed differences in the shape of the curve for the number of EA rosette-forming cells obtained with erythrocytes coated with decreasing concentrations of antibody. The results suggest that such curves and those obtained with EAC rosettes can be used to determine the relative abundance of EA and EAC receptors on rosette-forming cells. EA rosettes on the myeloid leukemic cells, like those on normal macrophages and granulocytes, were specifically inhibited by IgG2a and by the Fc but not the Fab fragment of IgG. The EAC rosettes were inhibited by destroying the C3 component of complement. The different clones maintained their specific properties for at least 6 months in culture. The present system should, therefore, also be useful for studies on the genetic control of the regulation of Fc and C3 receptors.

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007141 Immunoglobulin Fc Fragments Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin (COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport). This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fc Fragment,Fc Fragments,Fc Immunoglobulin,Fc Immunoglobulins,Ig Fc Fragments,Immunoglobulin Fc Fragment,Immunoglobulins, Fc,Immunoglobulins, Fc Fragment,Fc Fragment Immunoglobulins,Fc Fragment, Immunoglobulin,Fc Fragments, Ig,Fc Fragments, Immunoglobulin,Fragment Immunoglobulins, Fc,Fragment, Fc,Fragments, Ig Fc,Immunoglobulin, Fc
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3

Related Publications

J Lotem, and L Sachs
July 1977, Nature,
J Lotem, and L Sachs
April 1976, Zeitschrift fur Immunitatsforschung, experimentelle und klinische Immunologie,
J Lotem, and L Sachs
April 1975, Journal of immunological methods,
J Lotem, and L Sachs
May 1980, Research in veterinary science,
J Lotem, and L Sachs
January 1993, European cytokine network,
J Lotem, and L Sachs
January 1982, The Journal of clinical investigation,
J Lotem, and L Sachs
June 1985, British journal of experimental pathology,
Copied contents to your clipboard!